Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

By Reding Kerryn  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)

By Modugno F.  

Cancer Causes and Control, Vol. 14, Iss. 5, 2003-06 ,pp. : 439-446

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors

By Awadelkarim Khalid   Aceto Gitana   Veschi Serena   Elhaj Ahmed   Morgano Annalisa   Mohamedani Ahmed   Eltayeb Elgaylani   Abuidris Dafaallah   Gioacchino Mario   Battista Pasquale   Verginelli Fabio   Cama Alessandro   Elwali Nasr   Mariani-Costantini Renato  

Breast Cancer Research and Treatment, Vol. 102, Iss. 2, 2007-04 ,pp. : 189-199

Springer Publishing Company

Access to resources Recommend Favorite

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer

By Narod Steven  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 581-583

Springer Publishing Company

Access to resources Recommend Favorite